z-logo
Premium
Successful thalidomide therapy for actinic prurigo in a European woman
Author(s) -
Holzer Anna,
Wolf Peter,
Legat Franz J.,
Kerl Helmut,
Hofer Angelika
Publication year - 2006
Publication title -
jddg: journal der deutschen dermatologischen gesellschaft
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.463
H-Index - 60
eISSN - 1610-0387
pISSN - 1610-0379
DOI - 10.1111/j.1610-0387.2006.06125.x
Subject(s) - medicine , dermatology , thalidomide , prurigo , photodermatosis , population , immunology , xeroderma pigmentosum , dna , genetics , environmental health , biology , multiple myeloma , dna damage
Summary Actinic prurigo is a rare, often difficult‐to‐treat, idiopathic photodermatosis. Actinic prurigo is divided into a hereditary form appearing in the Native American population and a sporadic form occurring in non‐Native Americans. We present a 28‐year‐old Caucasian woman who developed typical clinical signs and symptoms of actinic prurigo, just as had her mother and grandmother. The patient and her mother were HLA‐A24 and HLA‐DR 4 with the subtype HLA‐DRB1*0408. Based on clinical symptoms and the HLA pattern, the diagnosis of actinic prurigo was made. Treatment with thalidomide led to resolution of the disease. This case report of a Caucasian woman suffering from a hereditary form of actinic prurigo questions the established classification of actinic prurigo into a hereditary Native American form and a sporadic form occurring in the non‐Native American population.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom